Home > Drug Search >
  • company_query: Arisaph
  •   > 
Drug Filter
Category:
chemistry (24) biology (2)
Status:
Phase Ⅲ (2) Phase Ⅱ (11) Phase Ⅰ (11) IND Filing (2)
Clinical Stage:
Pending (2) Active (23)
Bio-Type:
Vaccine (1) Whole antibody (1)
Indication:
Squamous cell cancer (1) Acute coronary syndrome (ACS) (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (1) Arrhythmia (1) Arthritis (1) Breast cancer (1) Bronchiectasis (1) Cystic fibrosis (CF) (1) Depression (1) Dry eye disease (1) Dyslipidemia (1) Gastric cancer (1) Pancreatitis (1) HBV infection (1) Hematopoietic stem cell transplantation (HSCT) (1) Hypertension (1) Hypertriglyceridemia (1) Somatotropin deficiency (1) Lung cancer (1) Malignancies (2) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Peripheral arterial disease (PAD) (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Systemic lupus erythematosus (1) Type 2 diabetes (2) Colon cancer (1) Stroke (2) Metastatic non-small cell lung cancer (1) Diabetes (1) Renal carcinoma (1) Squamous cell carcinoma of head and neck cancer (SCCHN) (1) Glioma (1) Lipodystrophy (1) Tissue injury (1) Liver cancer (2) Pseudomonas aeruginosa infection (1) Alpha-1 antitrypsin deficiency (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top